CD20 molecule deficiency and carrier frequency: a village-based screening study
CD20 MFI, rather than CD20 percentage, appears to be a more informative indicator for identifying individuals with flow-cytometric patterns suggestive of putative carrier status. Flow cytometry may serve as a rapid and practical preliminary screening tool in community-based settings; however, confirmation of carrier status requires molecular genetic testing, and genetic counseling should be based on verified genotypic results.
Authors
- Mehmet Ali Karaselek (ORCID: https://orcid.org/0000-0003-3201-8945)
- Mustafa Gençeli
- Sevgi Keleş
- Ayşe Sümeyra Engin (ORCID: https://orcid.org/0009-0007-4766-2887)
- Serkan Küççüktürk
- Tuğçe Duran
- TUĞBA ESRA PEKCANDANOĞLU
- NAZİRE NUR ONAT
- MUHAMMED FURKAN ERDEN
- ŞÜKRÜ NAİL GÜNER
- BİLAL BOSTAN
- BÜŞRA YÜKSEL
- MAHMUT ESAD YURTSEVEN
- İSMAİL REİSLİ
- EBRU SÜMEN
Institutions
- Necmettin Erbakan University (TR)
- KTO Karatay University (TR)
- Karamanoğlu Mehmetbey University (TR)
Publication Details
- Journal
- TURKISH JOURNAL OF MEDICAL SCIENCES
- Published
- 2026-02-12
- DOI
- https://doi.org/10.55730/1300-0144.6157
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00